I-ARRS Imaging Molecular and Therapy ye-Prostate Cancer 2020

Isifundo Esigcwele Sevidiyo

UZOTHOLA ISIQINISEKISO NGOKUXELWA KWESIKHATHI SOKUPHILA KWESIKHATHI SOKUPHILA NGOKUSHESHA NGEMVA KOKUKHOKHWA

Ochwepheshe abavela eSociety of Nuclear Medicine and Molecular Imaging bazokhuluma ngobuchwepheshe obuphambili kunabo bonke bemithi yenuzi ekucabangeni nasekwelapheni umdlavuza wendlala yabesilisa. I-prostate specific membrane antigen (i-PSMA) ifundwe kabanzi njengokubhekiswa kokucabanga nokwelashwa komdlavuza wendlala yesinye futhi ngenxa yalokho futhi njengenhloso ye-theranostic. Ama-radiopharmaceuticals aqondiswe ku-PSMA wokucabanga nge-PET kanye nokulethwa kwemisebe yokwelapha manje asesivivinyweni sesigaba 3 futhi ngaleyo ndlela kungekudala angatholakalela ukwandisa kakhulu indima yemithi yenuzi ekunakekelweni kweziguli ezinomdlavuza wendlala yabesilisa.

Thola isikweletu ngejubane lakho ngoJuni 4, 2023 no qhubeka nokuthola amavidiyo akho kuze kube uJuni 5, 2030. Bona ngezansi ngemiphumela yokufunda nohlu lwamamojula nezinkulumo ezingazodwana.

Imiphumela yokufunda kanye namaModyuli  

Ngemuva kokuphothula le nkambo, umfundi kufanele akwazi:

• chaza amandla e-imaging ye-PSMA-PET yomdlavuza we-prostate
• xoxa ngokuhumusha kwe-PET okuqondiswe ku-PSMA
• xoxa ngezinkomba zomtholampilo zoku-oda i-fluciclovine-PET

ukufundwa

• Ukulawula Ukuhunyushwa Kwe-Fluciclovine-PET—S. Galgano
• Ukucatshangelwa kwe-PET okubhekiswe ku-PSMA Komdlavuza We-Prostate—K. Zukotynski
• I-Theranostics Yomdlavuza We-Prostate—P. Kuo